Additional aetiological proteins for specific cancers have been identified, such as the role of higher levels of insulin-like growth factor-I in the development of breast7, colorectal8, and prostate9,10 cancers, and of higher microseminoprotein-beta with lower prostate cancer risk11. This evidence concerns the gene MSMB and cancer.